PRT-1419

N/A

Report date: 2024/06/13 15:52:24
NME

Base Information

Drug NamePRT-1419
Drug Alias NamePRT-1419
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInduced myeloid leukemia cell differentiation protein Mcl-1 inhibitors
TargetsInduced myeloid leukemia cell differentiation protein Mcl-1
Therapy Area/IndicationsMyeloproliferative DisordersMyelodysplastic SyndromesUterine Cervical Neoplasms +[18] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPrelude Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesPrelude Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMyelodysplastic SyndromesUterine Cervical NeoplasmsLung Neoplasms +[11] 
Inactive IndicationsMyeloproliferative DisordersLymphoma, Mantle-CellLymphoma, Follicular +[7] 

Other Information

ATC CodeN/A
Related LinksN/A